comparemela.com

Latest Breaking News On - Giovanni caforio - Page 2 : comparemela.com

Bristol-Myers Squibb Stock: Gloomy Q1 Earnings Trigger Justified Sell-Off (NYSE:BMY)

Bristol-Myers Squibb Stock: Gloomy Q1 Earnings Trigger Justified Sell-Off (NYSE:BMY)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Novartis raises guidance after beating Q1 expectations

It expects its 2024 net sales to grow by a high-single to low double-digit percentage with adjusted operating income growing by a low double-digit to mid-teens percentage, Novartis said in a statement.

Novartis Q1 Profit Tops Market, Lifts FY24 View, Proposes New Chair; Stock Up

Novartis AG's shares were gaining more than 4 percent in Switzerland and more than 5 percent in pre-market activity on the NYSE after the Swiss drug major reported Tuesday higher first-quarter profit, above market estimates, with strong sales growth.

Novartis proposes Giovanni Caforio as next chair

Novartis proposes Giovanni Caforio as next chair
swissinfo.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from swissinfo.ch Daily Mail and Mail on Sunday newspapers.

Novartis Proposes Giovanni Caforio As Next Chair

Novartis Proposes Giovanni Caforio As Next Chair
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.